Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin in papulopustular rosacea
NCT01359228Phase 2Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Apr 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in papulopustular rosacea, sponsored by University of California, San Francisco. Planned start Apr 2013; status: withdrawn.
02
Drugs
rifaximin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT01359228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01359228.